Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment

References

• WhittyJA, Rundle-Thiele SR, Scuffham PA, Rundle-Thiele SR, Scuffham PA. Insights into public preferences for pharmaceutical funding. Int J Pharm Healthc Mark. 2008;2(3):216–234.
   Google Scholar
• Mehralian G, Bastani P. Pharmaceutical strategic purchasing: a key to improve access to medicines. Iran J Pharm Res. 2015;14(2):345–346.
   PubMed Web of Science ®Google Scholar
• Whitty JA, Lancsar E, Rixon K, Golenko X, Ratcliffe J. A systematic review of stated preference studies reporting public preferences for healthcare priority setting. Patient. 2014;7(4):365–386.
   PubMedGoogle Scholar
• Lubans DR, Morgan PJ, Cliff DP, Barnett LM, Okely AD. Fundamental movement skills in children and adolescents: review of associated health benefits. Sports Med. 2010;40(12):1019–1035.
   PubMed Web of Science ®Google Scholar
• Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001;5(5):1–186.
   PubMedGoogle Scholar
• van Exel J, Baker R, Mason H, Donaldson C, Brouwer W, EuroVaQ Team. Public views on principles for health care priority setting: findings of a European cross-country study using Q methodology. Soc Sci Med. 2015;126:128–137.
   PubMed Web of Science ®Google Scholar
• Day B, Hanemann M, Hanley N, Hett T, Jones-Lee M, Loomes G, et al. Economic Valuation with Stated Preferences Techniques. Cheltenham: Edward Elgar Publishing;2002.
   Google Scholar
• Hensher D, Rose J, Greene W. Applied choice analysis: a primer. Cambridge: Cambridge University Press; 2005.
   Google Scholar
• Louviere JJ, Hensher DA, Swait JD. Stated choice methods: analysis and applications. Cambridge: Cambridge University Press;2000.
   Google Scholar
• Gerard K, Shanahan M, Louviere J. Using stated preference discrete choice modelling to inform health care decision-making: a pilot study of breast screening participation. Appl Econ. 2003;35(9):1073–1085.
   Web of Science ®Google Scholar
• Saloni Tanna. Priority Medicines for Europe and the World “A Public Health Approach to Innovation” Update on 2004 Background Paper. Publisher: World Health Organization. Chapter: 6.12 Osteoarthritis. 2013; (June):1–31. https://www.who.int/medicines/areas/priority_medicines/BP6_12Osteo.pdf
   Google Scholar
• King MT, Hall J, Lancsar E, Fiebig D, Hossain I, Louviere J, et al. Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ. 2007;16(7):703–717.
   PubMed Web of Science ®Google Scholar
• Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care.vol. 11. Dordrecht: Springer Science & Business Media; 2007.
   Google Scholar
• Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. Pharmacoeconomics. 2008.https://doi.org/10.2165/00019053-200826080-00004.
   PubMed Web of Science ®Google Scholar
• Mentzakis E, Stefanowska P, Hurley J. A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases: an exploratory study. Heal Econ Policy Law. 2011;6(3):405–433.
   PubMed Web of Science ®Google Scholar
• Afsharmanesh G, Mehralian G, Peiravian F. Attributes development for pharmaceutical subsidization: a qualitative study. Iran J Pharm Res. 2020;19(1):203–217.
   PubMed Web of Science ®Google Scholar
• Tappenden P, Brazier J, Ratcliffe J, Chilcott J. A stated preference binary choice experiment to explore NICE decision making. Pharmacoeconomics. 2007;25(8):685–93.https://doi.org/10.2165/00019053-200725080-00006.
   PubMed Web of Science ®Google Scholar
• Aguiar M, Benesch P, Watson V. Public Stated Preferences for pharmaceutical funding decisions. In: 13th National Conference on Health Economics. At: Braga, Portugal; 2013.
   Google Scholar
• Kløjgaard ME, Bech M, Søgaard R. Designing a stated choice experiment: the value of a qualitative process. J Choice Model. 2012;5(2):1–18.
   Web of Science ®Google Scholar
• Green C, Gerard K. Exploring the social value of health-care interventions: a stated preference discrete choice experiment. Health Econ. 2009;18(8):951–976.
   PubMed Web of Science ®Google Scholar
• Gallego G, Taylor SJ, McNeill P, Brien JE. Public views on priority setting for High Cost Medications in public hospitals in Australia. Heal Expect. 2007;10(3):224–235.
   PubMed Web of Science ®Google Scholar
• Dolan P, Shaw R, Tsuchiya A, Williams A. QALY maximisation and people’s preferences: a methodological review of the literature. Health Econ. 2005;14(2):197–208.
   PubMed Web of Science ®Google Scholar
• Schwappach DLB. Resource allocation, social values and the QALY: a review of the debate and empirical evidence. Heal Expect. 2002;5(3):210–222.
   PubMedGoogle Scholar